Details of the Drug

General Information of Drug (ID: DMJ2Y1C)

• Drug Name: CAP-1002

Indication

Disease Entry	ICD 11	Status	REF
Duchenne dystrophy	8C70	Phase 2	[1]
Myocardial infarction	BA41-BA43	Phase 1/2	[2]

• Cross-matching ID: TTD ID: D0MC5O
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03406780) A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-2). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02485938) HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne).